Tag: nasdaq:opnt

December 24, 2018

Opiant Pharmaceuticals, Inc. Announces FDA Orange Book Listing for New NARCAN Nasal Spray Patent

Opiant Pharmaceuticals (NASDAQ:OPNT), a specialty pharmaceutical company developing pharmacological treatments for addictions and drug overdose, today announced that its most...
September 25, 2018

Opiant Pharmaceuticals Announces Pricing of Public Offering of Common Stock

Opiant Pharmaceuticals (NASDAQ:OPNT), a specialty pharmaceutical company developing pharmacological treatments for addictions and drug abuse, today announced the pricing of...
September 21, 2018

Opiant Pharmaceuticals Announces Contract with Biomedical Advanced Research and Development Authority for Up to $4.6 Million to Accelerate Development of OPNT003

Opiant Pharmaceuticals (NASDAQ:OPNT), a specialty pharmaceutical company developing pharmacological treatments for addictions and drug overdose, today announced that it has...